These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9563656)

  • 21. Detection of rare mutant alleles by restriction endonuclease-mediated selective-PCR: assay design and optimization.
    Fuery CJ; Impey HL; Roberts NJ; Applegate TL; Ward RL; Hawkins NJ; Sheehan CA; O'Grady R; Todd AV
    Clin Chem; 2000 May; 46(5):620-4. PubMed ID: 10794742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A possible noninvasive method for the detection of bladder cancer in patients: microsatellite analysis of free DNA in urine and blood.
    Utting M; Werner W; Müller G; Schubert J; Junker K
    Ann N Y Acad Sci; 2001 Sep; 945():31-5. PubMed ID: 11708492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [p53 mutation in phenacetin-induced urothelial carcinomas].
    Petersen I; Ohgaki H; Ludeke BI; Kleihues P
    Verh Dtsch Ges Pathol; 1993; 77():252-5. PubMed ID: 7511292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allelic deletion fingerprinting of urine cell sediments in bladder cancer.
    Larsson PC; Beheshti B; Sampson HA; Jewett MA; Shipman R
    Mol Diagn; 2001 Sep; 6(3):181-8. PubMed ID: 11571711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
    Morimura K; Yamamoto S; Murai T; Mori S; Chen TX; Wanibuchi H; Fukushima S
    Carcinogenesis; 1999 Apr; 20(4):715-8. PubMed ID: 10223204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitive detection of p53 gene mutations by a 'mutant enriched' PCR-SSCP technique.
    Behn M; Schuermann M
    Nucleic Acids Res; 1998 Mar; 26(5):1356-8. PubMed ID: 9469850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular screening of multifocal transitional cell carcinoma of the bladder using p53 mutations as biomarkers.
    Xu X; Stower MJ; Reid IN; Garner RC; Burns PA
    Clin Cancer Res; 1996 Oct; 2(10):1795-800. PubMed ID: 9816132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation of the tumor suppressor gene p53 in human prostate and bladder cancers--investigation by temperature gradient gel electrophoresis (TGGE).
    Schlechte HH; Schnorr D; Löning T; Rudolph BD; Pohrt UM; Loening SA
    J Urol; 1997 Mar; 157(3):1049-53. PubMed ID: 9072541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progression in transitional cell carcinoma of the urinary bladder--analysis of Tp53 gene mutations by temperature gradients and sequence in tumor tissues and in cellular urine sediments.
    Schlechte HH; Sachs MD; Lenk SV; Brenner S; Rudolph BD; Loening SA
    Cancer Detect Prev; 2000; 24(1):24-32. PubMed ID: 10757120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunocytochemical detection of p53 in cultures of exfoliated cells from urine of patients with urothelial cancers.
    Okuno H; Kakehi Y; Ogawa O; Yamada H; Ozdemir E; Okada Y; Yoshida O
    Jpn J Cancer Res; 1996 Jul; 87(7):718-23. PubMed ID: 8698621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident.
    Yamamoto S; Romanenko A; Wei M; Masuda C; Zaparin W; Vinnichenko W; Vozianov A; Lee CC; Morimura K; Wanibuchi H; Tada M; Fukushima S
    Cancer Res; 1999 Aug; 59(15):3606-9. PubMed ID: 10446970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified Proofreading PCR for Detection of Point Mutations, Insertions and Deletions Using a ddNTP-Blocked Primer.
    Hao W; Fan L; Chen Q; Chen X; Zhang S; Lan K; Lu J; Zhang C
    PLoS One; 2015; 10(4):e0123468. PubMed ID: 25915410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms.
    Yamaguchi K; Sugano K; Fukayama N; Nakashima Y; Saotome K; Yokoyama T; Yokota T; Ohkura H
    Am J Gastroenterol; 1997 Feb; 92(2):307-12. PubMed ID: 9040212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tract.
    Stoehr R; Brinkmann A; Filbeck T; Gamper C; Wild P; Blaszyk H; Hofstaedter F; Knuechel R; Hartmann A
    Oncol Rep; 2004 Jan; 11(1):137-41. PubMed ID: 14654916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allele-specific PCR analysis of p53 codon 249 AGT transversion in liver tissues from patients with viral hepatitis.
    Kirby GM; Batist G; Fotouhi-Ardakani N; Nakazawa H; Yamasaki H; Kew M; Cameron RG; Alaoui-Jamali MA
    Int J Cancer; 1996 Sep; 68(1):21-5. PubMed ID: 8895534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of non-tumor cell contamination on detection of p53 gene mutations in human gastric cancer cells by polymerase chain reaction single-strand conformation polymorphism analysis.
    Hong WS; Hong SI; Lee DS; Son Y
    Korean J Intern Med; 1994 Jan; 9(1):20-4. PubMed ID: 8038143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.
    Kurtis B; Zhuge J; Ojaimi C; Ye F; Cai D; Zhang D; Fallon JT; Zhong M
    Ann Diagn Pathol; 2016 Apr; 21():7-11. PubMed ID: 27040924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids.
    Fliss MS; Usadel H; Caballero OL; Wu L; Buta MR; Eleff SM; Jen J; Sidransky D
    Science; 2000 Mar; 287(5460):2017-9. PubMed ID: 10720328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer.
    Yu J; Zhu T; Wang Z; Zhang H; Qian Z; Xu H; Gao B; Wang W; Gu L; Meng J; Wang J; Feng X; Li Y; Yao X; Zhu J
    Clin Cancer Res; 2007 Dec; 13(24):7296-304. PubMed ID: 18094410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High sensitive approach for point mutation detection based on electrochemiluminescence.
    Zhu D; Xing D; Shen X; Liu J; Chen Q
    Biosens Bioelectron; 2004 Oct; 20(3):448-53. PubMed ID: 15494224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.